Immunological features in the course of type 1 diabetes.
D000906:Antibodies / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D006680:HLA Antigens / Q000032:analysis; D006579:Heterozygote; D006801:Humans; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007330:Insulin Antibodies / Q000032:analysis; D007515:Islets of Langerhans / Q000276:immunology; D008214:Lymphocytes / Q000145:classification / Q000276:immunology; D014777:Virus Diseases / Q000150:complications
D000906:Antibodies; D006680:HLA Antigens; D007166:Immunosuppressive Agents; D007330:Insulin Antibodies; D003165:Complement System Proteins